Goupil Eugénie, Laporte Stéphane A, Hébert Terence E
Department of Pharmacology, McGill University, Montréal, Québec, Canada.
Methods Cell Biol. 2013;117:165-79. doi: 10.1016/B978-0-12-408143-7.00009-8.
G protein-coupled receptors (GPCRs) represent one of the largest families of cell surface receptors as key targets for pharmacological manipulation. G proteins have long been recognized as allosteric modulators of GPCR ligand binding. More recently, small molecule allosteric modulators have now been widely characterized for a number of GPCRs, and some are now used clinically. Many studies have also underscored the importance of GPCR dimerization or higher-order oligomerization in the control of the physiological responses they modulate. Thus, allosterism can also, between monomer equivalents in the context of a dimer, oligomer, or receptor mosaic, influence signaling pathways downstream. It therefore becomes essential to characterize both small molecule allosteric ligands and allosteric interactions between receptors modulated by canonical orthosteric ligands, in a pathway-specific manner. Here, we describe a simple, radioligand-binding method, which is designed to probe for allosteric modulation mediated by any GPCR interactor, from small molecules to interacting proteins. It can also detect allosteric asymmetries within a GPCR heterodimer, via orthosteric or allosteric ligands. This assay measures time-dependent ligand occupancy of radiolabeled orthosteric or (with adaptations) allosteric ligands as modulated by either small molecules or receptor dimer partners bound or unbound with their own ligands.
G蛋白偶联受体(GPCRs)是细胞表面受体中最大的家族之一,是药物调控的关键靶点。长期以来,G蛋白一直被认为是GPCR配体结合的变构调节剂。最近,小分子变构调节剂已被广泛用于多种GPCR的表征,其中一些已应用于临床。许多研究还强调了GPCR二聚化或高阶寡聚化在调控其所介导的生理反应中的重要性。因此,在二聚体、寡聚体或受体嵌合体的单体等效物之间,变构作用也可以影响下游信号通路。因此,以通路特异性方式表征小分子变构配体以及由经典正构配体调节的受体之间的变构相互作用变得至关重要。在这里,我们描述了一种简单的放射性配体结合方法,该方法旨在探测由任何GPCR相互作用分子介导的变构调节,从小分子到相互作用蛋白。它还可以通过正构或变构配体检测GPCR异二聚体内的变构不对称性。该检测方法测量放射性标记的正构配体或(经过改进的)变构配体的时间依赖性配体占据情况,这些配体受与自身配体结合或未结合的小分子或受体二聚体伙伴的调节。